NCT06088082

Brief Summary

laparoscopic appendectomy is most common surgical procedure necessitates evidence-based clinical pathways such as Enhanced Recovery After Surgery (ERAS). The paradigm of surgery has been shifted from open to laparoscopic. Laparoscopic appendectomy is the most common procedure performed in our institute for acute and chronic appendicitis. Pain control in ERAS is one of the key factors for improved outcomes. Surgery induced acute postoperative pain, stress response, and fatigue lead to prolonged convalescence and hospital stay. Optimal titrated safe postoperative pain management in laparoscopic appendectomy patients remains a challenge.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Oct 2023

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 16, 2023

Completed
5 months until next milestone

Study Start

First participant enrolled

October 1, 2023

Completed
17 days until next milestone

First Posted

Study publicly available on registry

October 18, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2024

Completed
19 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 20, 2024

Completed
Last Updated

October 18, 2023

Status Verified

October 1, 2023

Enrollment Period

6 months

First QC Date

May 16, 2023

Last Update Submit

October 14, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • to assess the pain score by verbal numerical rating scale[VNRS]

    to assess the pain score by using verbal numerical rating scale \[0-10\]in immediate postop period on arrival in PACU and then after 2,4,6,12 and 24 hours postop.between two groups.Low scores on verbal numerical rating scale will be beneficial factor in early discharge of patients from the hospital.

    7 months

Secondary Outcomes (3)

  • opiod consumption

    7 months

  • early mobility after surgery measured by john hopkins highest level of mobility scale[JH-HLM]

    7 months

  • to assess the severity of postoperative [PONV] during immediate postop and after 4,6,12 and 24 hours postop.

    7 months

Study Arms (2)

CONTROL GROUP

NO INTERVENTION

) will receive standard routine postoperative analgesia at our institute.

TREATMENT GROUP

EXPERIMENTAL

The patients will be divided into two groups; group-1 (n= 50) will receive pre-procedure right US-guided TAP and bilateral PRS blocks with bupivacaine 0.25% 20 ml for TAP block and 10 ml for PRS block .

Drug: Bupivacaine Hydrochloride

Interventions

Patients will be randomly assigned to receive a TAP and PRS blocks with 34 mL of 0.25% bupivacaine (study group) or standard hospital analgesia protocol (control group).

Also known as: TRASVERSE ABDOMINIS AND POSTERIOR RECTUS SHEATH BLOCKS
TREATMENT GROUP

Eligibility Criteria

Age14 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • American Society of Anesthesiologist \[ASA\] I-III patients
  • Age 14-60 years
  • Either gender
  • Patients scheduled for laparoscopic appendectomy.
  • Patient weight 50kg and above.

You may not qualify if:

  • American Society of Anesthesiologists (ASA) physical status IV
  • Patients with uncontrolled hypertension.
  • Anticipated difficult intubation.
  • Allergic to morphine
  • Allergic to bupivacaine
  • Clinically significant neurological, cardiovascular, renal hepatic disease planned for postoperative surgical intensive care (SICU) admission.
  • History of drug abuse or chronic opioid use
  • Laparoscopic procedure converted to open.
  • The patient weighed 100 kg and above.
  • Difficult anatomic landmarks on ultrasound scanning.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rashid Saeed Khokhar

Riyadh, Saudi Arabia

Location

Related Publications (12)

  • Robertson TC, Hall K, Bear S, Thompson KJ, Kuwada T, Gersin KS. Transversus abdominis block utilizing liposomal bupivacaine as a non-opioid analgesic for postoperative pain management. Surg Endosc. 2019 Aug;33(8):2657-2662. doi: 10.1007/s00464-018-6543-z. Epub 2018 Nov 2.

    PMID: 30390161BACKGROUND
  • Moradkhani M, Hejri P, Nadri S, Beiranvand S. Effects of ADJUVANT Ketamine on Induction of Anesthesia for the Cesarean Section. Curr Rev Clin Exp Pharmacol. 2021;16(2):197-200. doi: 10.2174/1574884715666200310103317.

    PMID: 32156239BACKGROUND
  • Alizadeh R, Aghsaie Fard Z. Renal impairment and analgesia: From effectiveness to adverse effects. J Cell Physiol. 2019 Aug;234(10):17205-17211. doi: 10.1002/jcp.28506. Epub 2019 Mar 27.

    PMID: 30916404BACKGROUND
  • Beiranvand S, Karimi A, Vahabi S, Amin-Bidokhti A. Comparison of the Mean Minimum Dose of Bolus Oxytocin for Proper Uterine Contraction during Cesarean Section. Curr Clin Pharmacol. 2019;14(3):208-213. doi: 10.2174/1574884714666190524100214.

    PMID: 31124424BACKGROUND
  • Ma N, Duncan JK, Scarfe AJ, Schuhmann S, Cameron AL. Clinical safety and effectiveness of transversus abdominis plane (TAP) block in post-operative analgesia: a systematic review and meta-analysis. J Anesth. 2017 Jun;31(3):432-452. doi: 10.1007/s00540-017-2323-5. Epub 2017 Mar 7.

    PMID: 28271227BACKGROUND
  • Beiranvand S, Sorori MM. Pain management using nanotechnology approaches. Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):462-468. doi: 10.1080/21691401.2018.1553885.

    PMID: 30688094BACKGROUND
  • Tupper-Carey DA, Fathil SM, Tan YK, Kan YM, Cheong CY, Siddiqui FJ, Assam PN. A randomised controlled trial investigating the analgesic efficacy of transversus abdominis plane block for adult laparoscopic appendicectomy. Singapore Med J. 2017 Aug;58(8):481-487. doi: 10.11622/smedj.2016068. Epub 2016 Apr 8.

    PMID: 27056207BACKGROUND
  • Alizadeh R, Mireskandari SM, Azarshahin M, Darabi ME, Padmehr R, Jafarzadeh A, Aghsaee-Fard Z. Oral clonidine premedication reduces nausea and vomiting in children after appendectomy. Iran J Pediatr. 2012 Sep;22(3):399-403.

    PMID: 23400517BACKGROUND
  • Khoo CK, Vickery CJ, Forsyth N, Vinall NS, Eyre-Brook IA. A prospective randomized controlled trial of multimodal perioperative management protocol in patients undergoing elective colorectal resection for cancer. Ann Surg. 2007 Jun;245(6):867-72. doi: 10.1097/01.sla.0000259219.08209.36.

    PMID: 17522511BACKGROUND
  • Muller S, Zalunardo MP, Hubner M, Clavien PA, Demartines N; Zurich Fast Track Study Group. A fast-track program reduces complications and length of hospital stay after open colonic surgery. Gastroenterology. 2009 Mar;136(3):842-7. doi: 10.1053/j.gastro.2008.10.030. Epub 2008 Nov 1.

    PMID: 19135997BACKGROUND
  • Stokes AL, Adhikary SD, Quintili A, Puleo FJ, Choi CS, Hollenbeak CS, Messaris E. Liposomal Bupivacaine Use in Transversus Abdominis Plane Blocks Reduces Pain and Postoperative Intravenous Opioid Requirement After Colorectal Surgery. Dis Colon Rectum. 2017 Feb;60(2):170-177. doi: 10.1097/DCR.0000000000000747.

    PMID: 28059913BACKGROUND
  • Beverly A, Kaye AD, Ljungqvist O, Urman RD. Essential Elements of Multimodal Analgesia in Enhanced Recovery After Surgery (ERAS) Guidelines. Anesthesiol Clin. 2017 Jun;35(2):e115-e143. doi: 10.1016/j.anclin.2017.01.018.

    PMID: 28526156BACKGROUND

MeSH Terms

Interventions

Bupivacaine

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Officials

  • rashid khokhar, fcps

    King Saud Medical City

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
. All patients, care providers in PACU \& ward (nurses), and outcome assessors (assistant anesthesiologist) will be blinded to the group allocation. Only the assigned anesthesiologist responsible for perioperative care will be aware of the group allocation to treat any unwanted side effects during and after the
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: To evaluate the combined efficacy US-guided TAP block and PRS block in patients undergoing laparoscopic appendectomy. Early mobilization, opioid consumption, Postoperative Nausea \& Vomiting (PONV), length of hospital stay (LOS), patient satisfaction in patients scheduled for laparoscopic appendectomy.
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
consultant anesthetist

Study Record Dates

First Submitted

May 16, 2023

First Posted

October 18, 2023

Study Start

October 1, 2023

Primary Completion

April 1, 2024

Study Completion

April 20, 2024

Last Updated

October 18, 2023

Record last verified: 2023-10

Locations